Notice of exclusive license agreement for artificially modified nucleic acid technology with Takeda Pharmaceutical Company Limited 2022/02/24 Notice Read
Achieved milestonesbased on the technology license agreement with Aligos Therapeutics. 2021/12/10 Notice Read
We will exhibit at the 3rd PharmaLab EXPO Tokyo [Pharmaceuticals] R & D exhibition booth. 2021/12/06 Event Read
Our President & CEO, Mr. Hideaki Sato, will participate in an event “Kansai Biomedical Research Group 14th Lecture” as a speaker. 2021/10/15 Event Read
Our President & CEO, Mr. Hideaki Sato, will participate in an event “The 15th WAKO Web Contract Seminar” as a speaker. 2021/10/12 Event Read
We will make a presentation at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society. 2021/09/22 Event Read
